Variant report
Variant | nsv961718 |
---|---|
Chromosome Location | chr2:56444857-56453716 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs114845440 | chr2:56444860-56444861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs386646361 | chr2:56444869-56444870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs554498047 | chr2:56444880-56444881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2869527 | chr2:56444887-56444888 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs111769644 | chr2:56444921-56444922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572825932 | chr2:56444923-56444924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530076437 | chr2:56444943-56444944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs550498914 | chr2:56444973-56444974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs374717044 | chr2:56445131-56445132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185422157 | chr2:56445156-56445157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs148695668 | chr2:56445165-56445166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141307107 | chr2:56445211-56445212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs17268653 | chr2:56445301-56445302 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs543310124 | chr2:56445347-56445348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs200066405 | chr2:56445358-56445359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567724862 | chr2:56445396-56445397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs727297 | chr2:56445414-56445415 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs557020877 | chr2:56445441-56445442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577057531 | chr2:56445460-56445461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2216324 | chr2:56445480-56445481 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs553110291 | chr2:56445489-56445490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561630031 | chr2:56445492-56445493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150773238 | chr2:56445533-56445534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541548938 | chr2:56445535-56445536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561319669 | chr2:56445569-56445570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530462676 | chr2:56445588-56445589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543831423 | chr2:56445595-56445596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189092288 | chr2:56445661-56445662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs116339353 | chr2:56445688-56445689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139663375 | chr2:56445699-56445700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566277134 | chr2:56445779-56445780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376799730 | chr2:56445789-56445790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs72801189 | chr2:56446002-56446003 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs567811486 | chr2:56446009-56446010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536689727 | chr2:56446042-56446043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556899560 | chr2:56446073-56446074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570682542 | chr2:56446106-56446107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs74834032 | chr2:56446155-56446156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552952274 | chr2:56446173-56446174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573078237 | chr2:56446178-56446179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535642122 | chr2:56446199-56446200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34733759 | chr2:56446213-56446214 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200518711 | chr2:56446226-56446227 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs555144531 | chr2:56446228-56446229 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560682986 | chr2:56446236-56446237 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576000942 | chr2:56446274-56446275 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147689684 | chr2:56446308-56446309 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs140743448 | chr2:56446334-56446335 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs17047627 | chr2:56446345-56446346 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374723935 | chr2:56446346-56446347 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56438400-56446200 | Weak transcription | HSMM | muscle |
2 | chr2:56439600-56451000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
3 | chr2:56446200-56446800 | Strong transcription | HSMM | muscle |
4 | chr2:56446800-56454600 | Weak transcription | HSMM | muscle |
5 | chr2:56451000-56451400 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr2:56451200-56452000 | Enhancers | HUVEC | blood vessel |
7 | chr2:56451400-56451600 | Flanking Active TSS | Muscle Satellite Cultured Cells | -- |
8 | chr2:56451600-56452000 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr2:56452000-56453000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
10 | chr2:56452000-56454400 | Weak transcription | HUVEC | blood vessel |
11 | chr2:56453000-56454800 | Enhancers | Muscle Satellite Cultured Cells | -- |